Arnold Marcel, Fischer Urs, Schroth Gerhard, Nedeltchev Krassen, Isenegger Joerg, Remonda Luca, Windecker Stephan, Brekenfeld Caspar, Mattle Heinrich P
Department of Neurology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland.
Stroke. 2008 May;39(5):1491-5. doi: 10.1161/STROKEAHA.107.506279. Epub 2008 Mar 6.
For selected stroke patients, intra-arterial thrombolysis (IAT) has been shown to be an effective treatment option. However, knowledge of safety and efficacy of IAT in patients with acute stroke as a complication of arterial catheter interventions is limited.
We analyzed clinical radiological findings and functional outcomes in consecutive patients 3 months after treatment with IAT for peri-procedural strokes occurring during neuroendovascular or cardiac catheter interventions. To measure outcome, the modified Rankin scale score was used.
Of a total of 432 patients treated with IAT, 12 (4 women and 8 men; mean age, 60 years) were treated because of an ischemic stroke after a neuro-endovascular procedure (n=6) or coronary angiography (n=6). The median baseline National Institutes of Health Stroke Scale score was 15. Recanalization was complete (thrombolysis in myocardial infarction grade 3) in 6, partial (thrombolysis in myocardial infarction 2) in 5, and minimal (thrombolysis in myocardial infarction 1) in 1. Nine patients (75%) had a favorable outcome (modified Rankin scale score, 0 to 2), and 3 had a poor outcome (modified Rankin scale score, 3 or 4). All patients with complete recanalization had a favorable outcome, whereas only 3 of 6 patients with partial or minimal recanalization (P=0.18) had a favorable outcome. Follow-up brain imaging was normal in 2 and showed new ischemic lesions in 10 patients. Two patients (17%) had a symptomatic intracerebral hemorrhage.
In acute stroke attributable to arterial catheter interventions, IAT is feasible and has the potential to improve outcome in these patients. A high recanalization rate could be achieved.
对于部分卒中患者,动脉内溶栓(IAT)已被证明是一种有效的治疗选择。然而,关于IAT在急性卒中患者中作为动脉导管介入并发症的安全性和有效性的了解有限。
我们分析了在神经血管内或心脏导管介入过程中发生围手术期卒中并接受IAT治疗的连续患者在治疗3个月后的临床影像学检查结果和功能转归。使用改良Rankin量表评分来衡量转归。
在总共432例接受IAT治疗的患者中,有12例(4名女性和8名男性;平均年龄60岁)因神经血管内手术后(n = 6)或冠状动脉造影后(n = 6)发生缺血性卒中而接受治疗。美国国立卫生研究院卒中量表评分的基线中位数为15分。再通情况为:6例完全再通(心肌梗死溶栓分级3级),5例部分再通(心肌梗死溶栓2级),1例轻微再通(心肌梗死溶栓1级)。9例患者(75%)转归良好(改良Rankin量表评分0至2分),3例转归不良(改良Rankin量表评分3或4分)。所有完全再通的患者转归良好,而部分或轻微再通的6例患者中只有3例(P = 0.18)转归良好。2例患者的随访脑成像正常,10例患者显示有新的缺血性病变。2例患者(17%)发生有症状的脑出血。
在动脉导管介入所致的急性卒中中,IAT是可行的,并且有可能改善这些患者的转归。可以实现较高的再通率。